Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients.
about
Genetic epidemiology. Psoriatic arthritisAnti-cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature reviewAn evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapyPsoriasis: classical and emerging comorbiditiesPsoriasis patients are enriched for genetic variants that protect against HIV-1 diseasePerformance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phasThe GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomesRisk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.Psoriatic arthritis: Epidemiology, diagnosis, and treatment.Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal studyEffect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyTumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitorsUsefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis.Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound.Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised plaDiagnosing Psoriatic Arthritis from the Dermatologist's View.Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.Psoriatic arthritis: epidemiology, clinical features, course, and outcome.Psoriatic arthritis assessment tools in clinical trials.Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis.Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.Predictors for radiological damage in psoriatic arthritis: results from a single centre.Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate.HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis.Classification and diagnostic criteria for psoriatic arthritis.Psoriatic arthritis and imaging.Ultrasound Findings in Hand Joints Involvement in Patients with Psoriatic Arthritis and Its Correlation with Clinical DAS28 Score.Measuring disease activity in psoriatic arthritis.Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgarisThe psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.Role of HLA-DR Alleles to Increase Genetic Susceptibility to Onychomycosis in Nail Psoriasis.Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis.Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort.Clinical and radiological damage in psoriatic arthritis.Cytokine blockers in psoriatic arthritis.
P2860
Q24806228-4F7DD784-54AE-4CD1-862C-CC6CFC3791D4Q27001098-B47E2BB9-5D48-4056-A8A1-95B30F0CD6A7Q28074393-51E09227-02F7-4632-8B2D-47DE7B730C78Q28088340-71AEEA7C-8CA9-4815-AD57-42334A5016D6Q28483308-5B4BE4EE-B86B-4274-A0CA-420460496997Q31038425-9EA4AFB6-3763-43DC-A92A-876D82DDCA92Q31169591-2C3AE646-838C-43CA-84FC-908BC8A55FD9Q33659249-7BC4770A-0994-403C-8D7A-6E08758A5628Q33916770-AF0304CE-1A1B-43DC-89D3-4A9AFE249845Q34027596-2FD28A88-B163-4D4C-9844-99C0E229F48DQ34047760-9BA6D0DA-1FAC-482F-BEF8-10011CBB06EAQ34174214-8A6A22F5-C1B4-402B-A990-7E695B49C364Q34228353-E8A2D427-016F-45CF-9505-E0B8E31B3556Q34550167-3E6519FC-9FEF-43C0-893F-D99B88460F80Q34725620-43FB8B50-4011-4EFD-A0F0-4F61CD0B6A6BQ34803594-52897BC1-3A3C-4FCD-A561-450653F42E05Q34818891-6528B270-4AB2-48C2-B414-AB148A2D3399Q35332756-5CC570D9-A0BF-47F8-8F0D-A3F4753040DCQ35549724-A2FBFD60-D903-4BC3-A4CF-0427B506F126Q35555905-F94D8527-7CBB-4E4F-B494-1B3387D4D54CQ35579437-A9B0E0AF-2FDA-452E-8CC5-65214F03B15CQ35579462-CCEFD0EB-C9D5-492F-952B-21008027AE79Q35636983-E678D21B-9830-4B05-B0F8-172D4F5E87A6Q35638304-FF4301EA-5907-4B1B-A64C-6D39FDFAB6E1Q35638631-6CAF6038-E488-4B71-BF21-327A434815AFQ35760034-CB39C5E0-2849-4C64-8036-A70F557B3F57Q35760136-DA3AC180-B579-4269-9BE8-D531230421E5Q35953347-FCDE0B4D-96AD-4388-801C-9B47FD29161FQ36040045-8351D40C-38A5-48CC-8582-1E4572585803Q36040064-19BA0B16-A384-46C6-9224-AA97891A5E2BQ36429155-ED60D14E-3591-4FF2-A94E-DA9D6FB7C7D5Q36520126-8D0FF3DB-7F54-4381-8496-5CD00B207913Q36733774-E5666CBA-8A3C-4E7C-96D0-A91FD644C842Q36940942-1EC07D29-D7AB-4D81-AFB8-E61EBF4CE3F4Q37394677-86F178E0-298B-4783-A709-E23D920BC409Q37465550-7E87102F-B1F0-4870-9628-5DF3785F32B4Q37520856-BE8F1C2C-B378-49C4-9D4E-5C2D16BF18D5Q39367830-A97A9951-42CA-4CBA-873C-C25D6D736B42Q42174115-6CC3F6E0-FBF9-49D6-9CBF-156B4C4293D0Q43018087-77BBFA3A-34EB-4192-96B1-858C94333B10
P2860
Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@en
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@nl
type
label
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@en
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@nl
prefLabel
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@en
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@nl
P2093
P1476
Psoriatic arthritis (PA): a cl ...... logical study of 180 patients.
@en
P2093
Arribas Castrillo JM
Ballina Garcia J
Lopez Larrea C
Riestra Noriega JL
Rodriguez Perez A
Torre Alonso JC
P304
P577
1991-08-01T00:00:00Z